DPA‐Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202203252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Xuan Nie und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,…. Hauptthemen laut MEDLINE: Zinc, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Gene therapy holds great promise as an effective treatment for many diseases of genetic origin. Gene therapy works by employing cationic polymers, liposomes, and nanoparticles to condense DNA into polyplexes via electronic interactions. Then, a therapeutic gene is introduced into target cells, thereby restoring or changing cellular function. However, gene transfection efficiency remains low in vivo due to high protein binding, poor targeting ability, and substantial endosomal entrapment. Artificial sheaths containing PEG, anions, or zwitterions can be introduced onto the surface of gene carriers to prevent interaction with proteins; however, they reduce the cellular uptake efficacy, endosomal escape, targeting ability, thereby, lowering gene transfection. Here, it is reported that linking dipicolylamine‐zinc (DPA‐Zn) ions onto polyplex nanoparticles can produce a strong hydration water layer around the polyplex, mimicking the function of PEGylation to reduce protein binding while targeting cancer cells, augmenting cellular uptake and endosomal escape. The polyplexes with a strong hydration water layer on the surface can achieve a high gene transfection even in a 50% serum environment. This strategy provides a new solution for preventing protein adsorption while improving cellular uptake and endosomal escape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
- Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Nie, X., You, W., Zhang, Z., Gao, F., Zhou, X. H., Wang, H. L., Wang, L. H., Chen, G., Wang, C. H., Hong, C. Y., Shao, Q., Wang, F., Xia, L., Li, Y., & You, Y. Z. (2023). DPA‐Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202203252
Vancouver
Nie X, You W, Zhang Z, Gao F, Zhou XH, Wang HL, et al. DPA‐Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202203252
BibTeX
@article{Nie2023,
author = {Nie, Xuan and You, Wei and Zhang, Ze and Gao, Fan and Zhou, Xiao-Hong and Wang, Hai-Li and Wang, Long-Hai and Chen, Guang and Wang, Chang-Hui and Hong, Chun-Yan and Shao, Qi and Wang, Fei and Xia, Lei and Li, Yang and You, Ye-Zi},
title = {DPA‐Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202203252}
}
EUVIMED